Condition: Non-Alcoholic Fatty Liver Disease · Metabolic Encephalopathy · Obesity, Morbid · Sponsor: Esbjerg Hospital - University Hospital of Southern Denmark
Interested? Contact the study team ↓
Prospective non-randomized intervention case control study on patients with a BMI \> 35. The intervention group/cases (n=600) is comprised of bariatric patients who undergo bariatric surgery and the control group (n=600) of age, weight and comorbidity matched patients who choose not to undergo bariatric surgery. The overall aim is to examine prevalence of the spectrum of fatty liver disease (NAFLD) in these patients and the prognostic significance of NAFLD.
This description comes directly from the study's public registry record.
Mette M Lauridsen, MD PhD · 4579182000 · mette.enok.munk.lauridsen@rsyd.dk
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria case group: * Age \> 18 years * BMI \>35 kg/m2 and referred for bariatric surgery at Hospital of South West Jutland, Denmark * Able to give written informed consent. Inclusion criteria control group: * Age \> 18 years * BMI \>35 kg/m2 with no wish to undergo bariatric surgery. * Able to give written informed consent. Exclusion Criteria: * Active viral hepatitis * Not willing or able to consent * Contraindications to liver biopsy
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Hospital of Southwest Jutland | Esbjerg, Denmark | Recruiting |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.